Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001144204-18-059997
Filing Date
2018-11-14
Accepted
2018-11-14 16:42:08
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 tv507201_s3.htm S-3 157830
2 EXHIBIT 5.1 tv507201_ex5-1.htm EX-5.1 10041
3 EXHIBIT 23.1 tv507201_ex23-1.htm EX-23.1 2941
4 GRAPHIC tv507201_img2.jpg GRAPHIC 8231
5 GRAPHIC tv507201_img3.jpg GRAPHIC 368
6 GRAPHIC tv507201_img1.jpg GRAPHIC 5484
  Complete submission text file 0001144204-18-059997.txt   191704
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

EIN.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-228383 | Film No.: 181184634
SIC: 2836 Biological Products, (No Diagnostic Substances)